Solid Biosciences (NASDAQ: SLDB) director details spouse RSU sale
Rhea-AI Filing Summary
Solid Biosciences Inc. director Ilan Ganot reported equity transactions related to spouse-held awards and updated his share holdings. On January 3, 2026, 2,994 restricted stock units held by his wife converted into 2,994 shares of common stock, reflecting one-for-one conversion of these awards. On January 5, 2026, 1,053 shares of common stock associated with his wife were sold at $5.43 per share to cover withholding taxes after the vesting of previously granted restricted stock units, and the filing notes these sales do not represent a discretionary trade by Ms. Ganot.
Following these transactions, 17,278 shares of common stock are reported as indirectly owned through his wife. The filing also reports 95,413 shares of common stock held directly by Mr. Ganot (including shares held jointly with Annie Ganot) and 19,394 shares held in the Ilan Ganot 2017 Irrevocable Trust, for which Adam and Annie Ganot serve as trustees.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,053 | $5.43 | $6K |
| Exercise | Restricted Stock Units | 2,994 | $0.00 | -- |
| Exercise | Common Stock | 2,994 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Restricted stock units convert to common stock on a one-for-one basis. This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot. Represents 91,371 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017. On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.
FAQ
What insider activity did SLDB director Ilan Ganot report on this Form 4?
The Form 4 reports that 2,994 restricted stock units held by his wife converted into common stock on January 3, 2026, and that 1,053 shares of common stock associated with his wife were sold on January 5, 2026 at $5.43 per share to cover withholding taxes after vesting.
How do the restricted stock units reported by SLDB convert to common stock?
The filing explains that the restricted stock units convert to common stock on a one-for-one basis. In this case, 2,994 restricted stock units converted into 2,994 shares of Solid Biosciences common stock.
What does the SLDB Form 4 disclose about the Ilan Ganot 2017 Irrevocable Trust?
The Form 4 states that 19,394 shares of Solid Biosciences common stock are held by Adam Ganot and Annie Ganot, and their successors, as trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
What was the original grant for the restricted stock units linked to the 2026 SLDB transactions?
The filing notes that on January 3, 2023, Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on each anniversary of the grant date, which led to the 2,994-unit conversion reported for January 3, 2026.